Viatris Inc's (NASDAQ: VTRS) Mylan is voluntarily recalling one lot of Octreotide Acetate Injection, 500 mcg/mL, packaged in a carton of ten 1mL syringes due to a product complaint of the presence of ...

Please provide your email address to receive an email when new articles are posted on . Once-monthly subcutaneous octreotide was associated with persistent control of IGF-I and growth hormone levels ...

The primary objective of this study was to assess preferences of nurses between injecting with the Somatuline ® Depot syringe and the syringe for long-acting release octreotide. Nurses attended a ...

Syringe and Vials To date, the Company has not received any reports of adverse reactions related to this recall. Mylan Institutional LLC, a Viatris Company, has voluntarily recalled 1 lot of ...

PARIS, France, 8 March 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) published today new data from seven abstracts to be presented at the hybrid-setting 19 th Annual European Neuroendocrine Tumor Society ...

Dear Dr. Roach: I give my wife an octreotide intramuscular injection monthly into the gluteal muscle. I was taught to pull back on the needle to be sure you aren’t in a blood vessel. Sometimes, I am ...

Dr. Keith Roach writes a medical question-and-answer column weekdays. Dear Dr. Roach: I give my wife an octreotide intramuscular injection monthly into the gluteal muscle. I was taught to pull back on ...

– In PRESTO, almost all nurse participants (97.8%) reported a preference* for the Somatuline® Depot (lanreotide) redesigned pre-filled syringe compared with the syringe for long-acting release ...

Dear Dr. Roach: I give my wife an octreotide intramuscular injection monthly into the gluteal muscle. I was taught to pull back on the needle to be sure you aren't in a blood vessel. Sometimes, I am ...